STOCK TITAN
  1. Home
  2. Sec-filings
  3. PGEN
  4. [Form 4] PRECIGEN, INC. Insider Trading Activity

Director at Precigen (NASDAQ: PGEN) granted stock, RSUs and options

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

PRECIGEN, INC. director Fred Hassan reported receiving new equity awards as compensation. He was granted 35,612 restricted stock units and an option for 41,073 shares of common stock at an exercise price of $3.51 per share, both dated March 10, 2026. He also received 17,948 shares of common stock, with a footnote stating these shares were issued in lieu of an annual cash retainer of $63,000. The restricted stock units vest in full on March 10, 2027, and the stock option expires on March 10, 2036. Following these awards, Hassan directly owns 1,171,400 shares of Precigen common stock.

Positive

  • None.

Negative

  • None.
Insider Hassan Fred
Role Director
Type Security Shares Price Value
Grant/Award Restricted Stock Units 35,612 $0.00 --
Grant/Award Option to Purchase Common Stock (Right to Buy) 41,073 $0.00 --
Grant/Award Common Stock 17,948 $3.51 $63K
Holdings After Transaction: Restricted Stock Units — 35,612 shares (Direct); Option to Purchase Common Stock (Right to Buy) — 41,073 shares (Direct); Common Stock — 1,171,400 shares (Direct)
Footnotes (1)
  1. The shares were issued to the reporting person in lieu of an annual retainer of $63,000. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. The RSUs vest in full on March 10, 2027.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Hassan Fred
(Last) (First) (Middle)
20374 SENECA MEADOWS PARKWAY
(Street)
GERMANTOWN MD 20876
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
PRECIGEN, INC. [ PGEN ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
03/10/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 03/10/2026 A 17,948 A $3.51(1) 1,171,400 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (2) 03/10/2026 A 35,612 (3) (3) Common Stock 35,612 $0 35,612 D
Option to Purchase Common Stock (Right to Buy) $3.51 03/10/2026 A 41,073 03/10/2026 03/10/2036 Common Stock 41,073 $0 41,073 D
Explanation of Responses:
1. The shares were issued to the reporting person in lieu of an annual retainer of $63,000.
2. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock.
3. The RSUs vest in full on March 10, 2027.
/s/ Fred Hassan, by Donald P. Lehr, as attorney-in-fact 03/12/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider equity awards did Precigen (PGEN) director Fred Hassan receive?

Fred Hassan received equity awards consisting of 35,612 restricted stock units, an option for 41,073 shares of Precigen common stock at $3.51 per share, and 17,948 shares of common stock as part of his director compensation package.

When do Fred Hassan’s Precigen (PGEN) restricted stock units vest?

Fred Hassan’s 35,612 restricted stock units vest in full on March 10, 2027. Each unit represents a contingent right to receive one share of Precigen common stock once vesting conditions are met, aligning his compensation with longer-term company performance.

What are the key terms of Fred Hassan’s Precigen (PGEN) stock option grant?

Fred Hassan was granted an option to purchase 41,073 shares of Precigen common stock at an exercise price of $3.51 per share. The option was granted on March 10, 2026 and is scheduled to expire on March 10, 2036, providing a long-term incentive.

How many Precigen (PGEN) shares does Fred Hassan hold after these transactions?

After the reported transactions, Fred Hassan directly owns 1,171,400 shares of Precigen common stock. This total reflects his updated holdings following the grant of 17,948 additional common shares as part of his director compensation on March 10, 2026.

How was Fred Hassan’s annual retainer paid in Precigen (PGEN) stock?

A footnote states that 17,948 shares of Precigen common stock were issued to Fred Hassan in lieu of an annual cash retainer of $63,000. This converts part of his director fees into equity, further tying his compensation to shareholder outcomes.

Do the Precigen (PGEN) restricted stock units each equal one common share?

Yes. A footnote explains that each restricted stock unit granted to Fred Hassan represents a contingent right to receive one share of Precigen common stock. Once the RSUs vest on March 10, 2027, they can be settled in an equivalent number of shares.